Cargando…
Modern insulins, old paradigms and pragmatism: choosing wisely when deciding how to treat type 1 diabetes
There is a clinical imperative to improve metabolic control in the treatment of patients with type 1 diabetes, but in doing so, hypoglycemia should be avoided at all costs. Insulin analogues and the assumption they would better mimic the pharmacokinetic profile of endogenous insulin secretion emerge...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426553/ https://www.ncbi.nlm.nih.gov/pubmed/25964802 http://dx.doi.org/10.1186/s13098-015-0033-4 |